A fire in a residential building in southeast Delhi’s Tughlakabad area killed three people and left two others in critical condition early Friday, June 12, 2026, officials said. The blaze was reported around 2.30 am from Gali No. 1, where flames broke out in the ground-floor parking area of a multi-storey building with five upper floors. The victims included a 22-year-old man and two women. Several residents were trapped inside the

Target has recalled select Up & Up baby wipes sold nationwide and online after FDA testing found bacterial contamination that could pose infection risks, especially for newborns, infants, young children and people with weakened immune systems. The voluntary recall was announced by Target on Thursday, June 4, 2026, and published by the U.S. Food and Drug Administration on Friday, June 5, 2026. The recalled products include Up & Up Fragrance Free Baby Wipes and Up & Up Fre

Haleon has recalled four lots of Gas-X Extra Strength Softgels after a possible coolant contamination issue during packaging. The Gas-X Extra Strength recall affects 125 mg softgels in 120-count and 72-count bottles distributed to the consumer level beginning Monday, April 13, 2026, according to a company announcement published by the U.S. Food and Drug Administration on Thursday, June 4, 2026. Gas-X Extra Strength Recall Covers Four Lots The r

Dr. Marty Makary Resigns as FDA Commissioner Dr. Marty Makary has resigned from his position as the commissioner of the U.S. Food and Drug Administration (FDA), as confirmed by President Donald Trump on May 12. In a social media post, Trump revealed that Makary had informed him of his decision to step down, effective Tuesday. While Makary did not offer an explicit reason for his resignation, Trump praised his leadership, calling him a “hard worke

Potato Chip Recall: What Consumers Need to Know A potato chip recall has been issued for select Zapp’s and Dirty brand chips after Utz Quality Foods warned of a possible salmonella risk linked to seasoning. Consumers should not eat the affected products and should discard recalled bags immediately. Why Utz Recalled Zapp’s and Dirty Chips Utz said the voluntary recall followed notice that a seasoning ingredient containing

U.S. President Donald Trump announced a sweeping policy shift on Saturday, April 18, aimed at accelerating access to medical research and treatments involving psychedelic drugs. The executive order, signed in the Oval Office, directs the US Food and Drug Administration to expedite the review process for substances such as ibogaine, which some veteran advocacy groups say may help treat post-traumatic stress disorder. The signing event included federal health officials, advocates, and podcaster Joe Rogan, highlighting growing public and institutional interest in alternative mental health therapies. Focus on veterans and severe mental illness treatment Trump said the initiative is designed to “dramatically accelerate access” to experimental therapies that have shown potential in addressing severe mental health conditions. He emphasized that these treatments could be particularly impactful for U.S. military veterans suffering from PTSD and depression. The order instructs federal agencies to reduce administrative barriers, enhance data sharing between the FDA and the Department of Veterans Affairs, and streamline the process for rescheduling psychedelic substances once they receive regulatory approval. Funding and expanded access under Right to Try law As part of the initiative, the federal government will allocate $50 million to support state-level research on ibogaine. The administration is also expanding pathways for patients with critical conditions to access experimental treatments under the Right to Try law enacted during Trump’s first term. Officials said this approach could allow certain patients to receive psychedelic-based therapies before full FDA approval, provided safety protocols are followed. Health officials cite urgency of mental health crisis Health and Human Services Secretary Robert F Kennedy Jr. described the executive order as a decisive step in addressing what he called one of the nation’s most pressing public health challenges. He said the policy would remove legal and regulatory barriers that have historically limited research into psychedelic treatments. Kennedy added that the changes aim to enable scientists, clinicians, and researchers to better study these substances and, where appropriate, develop safe therapeutic protocols for their use in treating mental health conditions.  

A nationwide recall has been issued for a specific lot of the widely prescribed anxiety medication Xanax after federal regulators identified a potential quality issue that could affect how the drug performs in patients. According to the U.S. Food and Drug Administration, pharmaceutical company Viatris initiated a voluntary recall on Monday, March 17, 2025. The recall involves one lot of extended-release tablets that failed to meet required dissolution specifications, a standa

Consumers in the United States who purchased Tom’s toothpaste products within the past six years may be eligible for compensation under a $2.9 million class-action settlement involving Colgate-Palmolive Company. The lawsuit alleged deceptive and misleading business practices related to the manufacturing, marketing, and sale of certain Tom’s toothpaste products, following concerns raised during a U.S. Food and Drug Administration inspection of a production facility in Sanford, Maine in May 20

A California-based pharmaceutical company has expa

Keurig has issued a voluntary recall of more than 80,000 decaf coffee pods after discovering that the products may contain caffeine. The recall applies specifically to K-Cup pods labeled as McCafe Premium Roast Decaf Coffee, with a best-by date of November 17, 2026, and a UPC code of 043000073438. Consumers who purchased these pods are advised to check their inventory, as the product may not meet its labeled decaf specifications. The recall was initially announced on December 6, 2025,

Federal regulators have announced a sweeping recall affecting hundreds of commonly purchased consumer products sold in small grocery stores and markets across parts of the Midwest, citing serious sanitation concerns that may pose a risk to public health. The action follows an inspection of a Minneapolis-based distribution facility that supplies food, medication, and household goods to retailers in Minnesota, Indiana, and neighboring states. According to the Food and Drug Administrat

In a major development for obesity treatment, the US Food and Drug Administration has approved the first oral version of Wegovy, marking a significant shift in how weight-loss medications can be administered. The approval was announced by Danish pharmaceutical giant Novo Nordisk, which described the tablet

Frozen shrimp sold at Jewel-Osco grocery stores in Illinois are being recalled following a federal investigation that raised concerns about possible contamination during handling and storage, according to the U.S. Food and Drug Administration. Federal officials said the affected shrimp may have been packaged, prepared, or held under insanitary conditions and could potentially contain trace amounts of radioactive material. The recall was issued Friday by Direct Source Seafood LLC, a

Thousands of cases of popular salad dressings distributed across the United States have been recalled after federal regulators identified the presence of foreign material in certain products, according to a recent enforcement report issued by the Food and Drug Administration. The recall involves products manufactured by California-based Ventura Foods and includes several well-known brands and private-label dressings sold through retail and food service channels. The recall was first

The U.S. Food and Drug Administration has released an updated notice regarding a nationwide recall of shredded cheese products distributed to several major retail chains, including Aldi, Target, and Walmart. According to the agency, more than 260,000 cases of shredded cheese may contain metal fragments, prompting officials to elevate their advisory and urge consumers to take immediate precautions. The update follows recent concerns in the dairy sector, including a separate recall involving Pr

WASHINGTON — The U.S. Food and Drug Administration (FDA) has announced a recall of certain lots of ByHeart Whole Nutrition Infant Formula following a multi-state investigation into a cluster of infant botulism cases. The outbreak, which spans ten states, has resulted in 13 hospitalizations since August, though no deaths have been reported. Federal health officials said the recall applies to two specific lots of ByHeart powdered formula with “use by” dates of December 1. The af

A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his

A popular brand of dog treats sold across several Midwestern states has been recalled after federal health officials found potential salmonella contamination that could endanger both pets and their owners. The Food and Drug Administration (FDA) issued a public warning this week, urging consumers to stop using and immediately discard the affected products. Best Buy Bones Inc., an all-natural pet treat manufacturer based in Mount Morris, Michigan, voluntarily recalled four lots of its

The dietary supplement industry, a multibillion-dollar market, continues to face challenges in Washington despite support from President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. Although the industry has grown in popularity, it is still waiting for significant policy changes that would make it easier for consumers to buy supplements and allow manufacturers more flexibility in making health claims.

A New Jersey man who was diagnosed with Parkinson’s disease in 2022 is speaking about how a new FDA approved medication has helped improve his daily life. Gasper Giordano was diagnosed just three years ago and soon began to experience many of the challenges that are common among Parkinson’s patients. He found himself struggling with balance, having trouble holding even simple objects like a glass, and facing difficulty writing his own name. His move